Trials / Not Yet Recruiting
Not Yet RecruitingNCT06824961
Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilation Success Rate and Return of Spontaneous Circulation?
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 692 (estimated)
- Sponsor
- Amsterdam UMC, location VUmc · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To give chest compressions during cardiopulmonary resuscitation (CPR), mechanical chest compression devices can be used. During synchronous 30:2 CPR, the standard setting on these devices leave an automated 3-second chest compression pause after 30 compressions to facilitate caregivers in providing two ventilations. With this standard setting, research has shown that in less than half of ventilation pauses during CPR, those two ventilations are given. Increasing the ventilation pause duration to 5 seconds instead of 3 seconds is also an option following current guideline recommendations, and aligns with measured ventilation pause duration in manual CPR. Increasing pause duration to 5 seconds could result in an increased ventilation success rate. This multicenter randomized controlled trial will randomize LUCAS® mechanical compression devices to a standard setting of 3- or 5-second compression pauses. The main outcome will be the percentage of ventilation pauses in which two ventilations are successfully given. Secondary outcomes include the restoration of spontaneous circulation (ROSC), and the difference in (neurologically intact) survival. No study has been performed to evaluate this effect yet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 5-second ventilation pause duration during mechanical CPR | The intervention is a 5-second lasting ventilation pause during mechanical CPR |
| OTHER | 3-second ventilation pause duration during mechanical CPR | The intervention is a 3-second lasting ventilation pause during mechanical CPR |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2026-09-01
- Completion
- 2027-04-01
- First posted
- 2025-02-13
- Last updated
- 2025-02-13
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06824961. Inclusion in this directory is not an endorsement.